A Novel Nanogel Formulation of Finasteride for Topical Treatment of Androgenetic Alopecia: Design, Characterization and In-vitro evaluation

  • DIVYA SANGANABHATLA Department of Pharmacy, University College of Technology, Osmania University, Hyderabad 500007, India
  • R. SHYAM SUNDER Department of Pharmacy, University College of Technology, Osmania University, Hyderabad 500007, India


The present paper describes the development and evaluation of a novel Finasteride (FSD) nanogel topical delivery for the treatment of Androgenetic Alopecia. Nano based topical formulation was chosen to enhance the solubility, permeability, biocompatibility of drug and to overcome the problems associated with the oral delivery of finasteride such as “gynecomastia, breast tenderness, malignant neoplasms of the male breast, decreased ejaculate volume, decrease in testicular size reduction in penile curvature, reduction in penile size, sexual disorder, male infertility” (USFDA,2017) . Glycerol monostearate (GMS), Transcutol HP and Tween 80 that showed the highest solubility and partition coefficient were selected as solid lipid, liquid lipid and surfactant respectively in the preparation of Nano structured lipid carrier (NLC). Various trails batches were prepared by using probe sonication method. Based on stability studies and particle size, NP3 trail was optimized. The optimized NP3 trail exhibited spherical shape with a mean diameter of 113.80±0.72, polydispersity of 0.28 ± 0.01, zeta potential of -25.2 mV, drug entrapment efficiency of 92.67±0.47 %, and drug loading of 6.15±0.02 %. Storage stability studies demonstrated that the particle size and entrapment efficiency of the FSD-NLCs were not changed during 3 months both at 4°C and room temperature. Finasteride NLCs were characterized for particle size by scanning electron microscope (SEM), chemical state by XRD, physical stability by centrifugation and thermodynamic stability by Freeze-thaw method. These prepared nanoparticles were transformed into topical nanogel. Different batches of NLC gel was prepared using gelling agent as Carbopol 934P (0.5, 1, 1.5%) (C1-C3) and Carbopol 974P (0.5, 1, 1.5%) (C4-C6) (USFDA). Among them, C2 trail has shown excellent gelling capacity, clear appearance, good viscosity characteristics and was selected for further studies. Batches of topical nanogel were characterized through pH, homogeneity, spreadability, viscosity, drug content and in vitro drug release study. Based on pH (6.5-6.8), drug content (91.25 ± 0.9%), spreadability (6.7 cm/sec), C2 batch was subjected to in vitro skin occlusivity study, invitro release study and invitro heamolysis study.

Keywords: Nanoparticles, Androgenetic Alopecia, Nano lipid Carrier (NLC), Finasteride (FSD)


1. U.S. Food and Drug administration databases. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020788s018lbl.pdf [Accessed July 07, 2017].
2. Ho CH, Sood T, Zito PM. 2020. Androgenetic Alopecia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishers.
3. Divya Sanganabhatla, Shyam Sunder R. A model for docking Finasteride to 5?-reductase. Online Journal of Bioinformatics, 2019; 20(3):182-193.
4. Lee, S. W., Juhasz, M., Mobasher, P., Ekelem, C., & Mesinkovska, N. A. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. Journal of drugs in dermatology, 2018; 17(4), 457–463.
5. Roque L, V, Dias I, S, Cruz N, Rebelo A, Roberto A, Rijo P, Reis C, P: Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia. Skin Pharmacology and Physiology, 2017; 30:197-204.
6. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, Weiss B, Schaefer UF, Lehr C-M, Wepf R.Nanoparticles - an efficient carrier for drug delivery into the hair follicles. European Journal of Pharmaceutics and Biopharmaceutics, 2007; 66:159-164.
7. Ahlin Grabnar P, Kristl J. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers. Journal of Microencapsulation, 2011; 28:323-335.
8. Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C: Nanocapsule technology: a review. Critical Review in Therapetic Drug Carrier System, 2002; 19:99-134.
9. Reis CP, Roque LV, Baptista M, Rijo P: Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. Pharmaceutical Development and Technology, 2016; 21:282-287.
10. Madheswaran T, Baskaran R, Thapa RK, Rhyu JY, Choi HY, Kim JO, Yong CS, Yoo BK: Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery. American Association of Pharmaceutical scientists Pharm SciTech, 2013; 14:45-52.
11. Divya S, Shyam sunder R. Development and validation of UV Spectrophotometric method for the estimation of finasteride drug. International Journal of Pharmaceutical Quality assurance, 2019; 10(3): 597-600.

12. Franklin SJ, Younis US, Myrdal PB. Estimating the Aqueous Solubility of Pharmaceutical Hydrates. Journal of pharmaceutical sciences, 2015; 105(6), 1914–1919.
13. Sharma A and Baldi A: Nanostructured Lipid Carriers: A review. Journal of developing drugs, 2018; 7(2): 1000191- 203
14. Priyanka J, Parshotam M, Senshang L. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation, Pharmaceutical Development and Technology,2014; 19(3): 373-384.
15. Ranpise NS, Korabu SS, Ghodake VN. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B Biointerfaces. 2014; 116:81-87.
16. Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. 2010; 74 (3):474-82.
17. Nasr M, Mansour S, Mortada ND, El Shamy AA. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2008; 9(1):154-62.
18. Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids in Health and Disease. 2009;8:6.
19. Slavomira D, Joana A, Garcia ML, Erik R, Eliana BS. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC) Colloids Surf B Biointerfaces. 2010; 75:538–542.
20. de Vringer, T., 1992. Topical preparation containing a suspensionof solid lipid particles. European Patent No. 91200664
21. Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmacy , 2004;278(1):71–7.

22. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semisolid lipid-based formulations. Advanced Drug Delivery Reviews, 2008; 60(6):734–46.

23. Malgope A, Murthy P, Ramani R, Dey S. Development of nanoemulsion as carrier for transdermal delivery of valsartan. International Journal of Pharmaceutical and Chemical Sciences. 2013; 2:1655-65.

24. Kotta S, Khan AW, Ansari S, Sharma R, Ali J. Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug delivery. 2015; 22(4):455-66.

25. Meghana G, VVSNR K, Talluri S, Gunda R, Channareddy S, Ganesh G. Formulation and evaluation of tolnaftate loaded topical liposomal gel for effective skin drug delivery to treat fungal diseases. Journal of Chemical and Pharmaceutical Research. 2014;6:856-66
26. Inamdar, Y., Rane, B., & Jain, A. (2018). Preparation and Evaluation of Beta sitosterol Nanogel: A Carrier Design for Targeted Drug Delivery system. Asian Journal of Pharmaceutical Research and Development, 6(3), 81-87.
27. Mei X Chen, Kenneth S Alexander, Gabriella B, Formulation and Evaluation of Antibacterial Creams and Gels Containing Metal Ions for Topical Application, Journal of Pharmaceutics, 2016; 1- 10.
28. Khalil, M , Ismail, E, El-Baghdady K , Doaa M. Green synthesis of silver nanoparticles using olive leaf extract and its antibacterial activity. Arabian Journal of Chemistry, 2013; 7(6):1131-1139.
29. Patel D, Dasgupta S, Dey S, Roja Ramani Y, Ray S, Mazumder B. Nanostructured Lipid Carriers (NLC)-Based Gel For The Topical Delivery Of Aceclofenac: Preparation, Characterization, And In Vivo Evaluation. Scientia Pharmaceutica. 2012; 80(3):749-764.
30. Pamudji JS, Mauludin R, Indriani N. Development of Nanostructured Lipid Carrier Formulation Containing Of Retinyl Palmitate. International Journal of Pharmacy and Pharmaceutical Sciences, 2016; 8(2): 256-60.
31. Khurana S, Bedi PMS, Jain NK. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam. Chemistry and Physics of Lipids, 2013; 175–176: 65-72.
32. Rajinikanth PS, Chellian J. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil. International journal of nanomedicine, 2016; 11, 5067–5077.
2 Views | Downloads
How to Cite
SANGANABHATLA, D., & SUNDER, R. S. (2021). A Novel Nanogel Formulation of Finasteride for Topical Treatment of Androgenetic Alopecia: Design, Characterization and In-vitro evaluation. International Journal of Applied Pharmaceutics, 13(4). https://doi.org/10.22159/ijap.2021v13i4.41599
Original Article(s)